In this sense, we hypothesized that, in FCH, a genetic model of dyslipidemia with a high risk of developing cardiovascular disease, there could be alterations in the CX3CL1/CX3CR1 axis modulated by the presence of insulin resistance and sex, which could explain why some are more prone to developing cardiovascular disease. Here, CX3CR1 is linked to metabolic syndrome.